37.35
-2.12 (-5.37%)
-2.12 (-5.37%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -2.12 | -5.37% | 37.35 | 17:15:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 39.47 | 37.185 | 39.475 | 37.35 | 39.47 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 37.20 | 39.48 | 2.28 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,203 | 1,004,801 | $ 37.87 | $ 38,049,114 | 1,405,457 | 18.70 - 54.2081 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:41:52 | 10 | $ 38.47 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 5.48B | 146.69M | 136.82M | $ - | $ - | -1.59 | -24.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 41.46 | 41.71 | 34.61 | 38.52 | 1,889,700 | -4.11 | -9.91% |
| 1 Month | 44.89 | 53.04 | 34.61 | 43.96 | 1,210,133 | -7.54 | -16.8% |
| 3 Months | 46.71 | 54.2081 | 34.61 | 46.74 | 1,286,767 | -9.36 | -20.04% |
| 6 Months | 34.50 | 54.2081 | 24.671 | 39.92 | 1,332,983 | 2.85 | 8.26% |
| 1 Year | 33.07 | 54.2081 | 18.70 | 34.79 | 1,573,703 | 4.28 | 12.94% |
| 3 Years | 17.90 | 54.2081 | 7.26 | 23.81 | 1,386,794 | 19.45 | 108.66% |
| 5 Years | 5.72 | 54.2081 | 4.24 | 21.33 | 1,003,996 | 31.63 | 552.97% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. |
